Skip to main content
Premium Trial:

Request an Annual Quote

EraGen Gets FDA OK for Herpes MDx Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – EraGen Biosciences has received US Food and Drug Administration clearance for its molecular test for herpes simplex virus, the firm said today.

The Madison, Wis.-based company said that its MultiCode-RTx HSV 1&2 Kit received 510(k) market clearance, which it said is the first molecular test for herpes simplex virus to be cleared by FDA. The test uses the firm's novel synthetic DNA base pair isoC:isoG, and detects and types HSV 1 and 2 DNA in vaginal lesions.

"With the clearance of EraGen's HSV 1&2 Kit, clinical laboratories can now provide PCR-based, qualitative detection of HSV types 1 or 2 as indicated in the package insert in approximately four hours utilizing a common nucleic acid extraction system and real-time PCR instrument," Maria Foster, EraGen's VP of commercial operations, said in a statement.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.